Stockscreener 앱 받기
0.849
2.30%
0.0191
시간 외 거래:
.85
0.001
+0.12%
전일 마감가:
$0.8299
열려 있는:
$0.84
하루 거래량:
54,031
Relative Volume:
0.41
시가총액:
$3.59M
수익:
$502.40K
순이익/손실:
$-7.91M
주가수익비율:
-0.0851
EPS:
-9.972
순현금흐름:
$-4.32M
1주 성능:
-9.68%
1개월 성능:
-16.76%
6개월 성능:
-58.99%
1년 성능:
-88.53%
1일 변동 폭
$0.8338
$0.858
1주일 범위
$0.78
$0.9841
52주 변동 폭
$0.78
$8.00
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
명칭
60 Degrees Pharmaceuticals Inc
전화
202-327-5422
주소
1025 CONNECTICUT AVENUE NW, WASHINGTON
SXTP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
0.849 | 3.51M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.52 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.79 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
862.05 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.10 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.46 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
60 Degrees Pharmaceuticals Inc 주식(SXTP)의 최신 뉴스
60 Degrees Pharmaceuticals (NASDAQ:SXTP) & Amneal Pharmaceuticals (NASDAQ:AMRX) Head to Head Analysis - Defense World
CEO Makes Bold Move with Major Stock Purchase in 60 Degrees Pharmaceuticals! - TipRanks
Dow, 60 degrees Pharmaceuticals CEO, buys $12k in SXTP stock - Investing.com India
60 Degrees Pharma to expand sales efforts after positive pilot results - Investing.com
60 Degrees Pharmaceuticals announces expansion of Arakoda sales and marketing in 2026 - marketscreener.com
60 Degrees Pharmaceuticals Announces Expansion Of Arakoda Sales And Marketing In 2026 - TradingView — Track All Markets
60 Degrees Pharma (NASDAQ: SXTP) to Double ARAKODA Sales Reps, Add Babesiosis Trial Sites - Stock Titan
Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22 - Daytona Beach News-Journal
60 Degrees Pharmaceuticals Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Daily Commercial
Gains Report: Can 60 Degrees Pharmaceuticals Inc stock maintain growth trajectory2025 Analyst Calls & Technical Pattern Based Signals - moha.gov.vn
Day Trade: Why 60 Degrees Pharmaceuticals Inc stock is considered a top pickJuly 2025 Rallies & Stock Portfolio Risk Management - moha.gov.vn
Can 60 Degrees Pharmaceuticals Inc. stock maintain growth trajectoryMarket Trend Review & Daily Stock Momentum Reports - Newser
Is 60 Degrees Pharmaceuticals Inc Equity Warrant a good long term investmentReal-Time Stock Alerts & Rapid Capital Trading Tips - earlytimes.in
Will 60 Degrees Pharmaceuticals Inc. stock deliver long term returnsNew Guidance & Weekly Breakout Opportunity Watchlist - BỘ NỘI VỤ
What You Should Know About Kohinoor Foods Limiteds Profitability RatiosMarket Volatility Update & Small Investment Portfolio - earlytimes.in
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given New $2.80 Price Target at Ascendiant Capital Markets - Defense World
Why 60 Degrees Pharmaceuticals Inc. stock is considered a top pickLayoff News & Smart Swing Trading Alerts - moha.gov.vn
Dick's Sporting Goods To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Ascendiant Capital Maintains 60 Degrees Pharmaceuticals (SXTP) Buy Recommendation - Nasdaq
Is 60 Degrees Pharmaceuticals Inc. stock a defensive play in 20252025 Top Gainers & Capital Efficient Trading Techniques - BỘ NỘI VỤ
How 60 Degrees Pharmaceuticals Inc. stock reacts to job market dataMarket Performance Report & Daily Stock Trend Watchlist - moha.gov.vn
60 Degrees Pharmaceuticals Inc. (SXTP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
60 Degrees Pharma begins enrollment for chronic babesiosis study By Investing.com - Investing.com Nigeria
60 Degrees Pharma begins enrollment for chronic babesiosis study - Investing.com India
60 Degrees Pharmaceuticals announces clinical site now open for patient enrollment - MarketScreener
60 Degrees Pharmaceuticals Launches First-Ever Study for Tafenoquine in Chronic Babesiosis Patients - Quiver Quantitative
60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine - The Manila Times
60 Degrees Pharmaceuticals Announces Clinical Site Now Open - GlobeNewswire
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock reach all time highs in 2025 - newser.com
How resilient is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock in market downturnsPortfolio Return Report & Low Volatility Stock Recommendations - newser.com
Is 60 Degrees Pharmaceuticals Inc. stock supported by innovation pipeline2025 Support & Resistance & Growth Focused Stock Pick Reports - newser.com
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Upgraded at Zacks Research - Defense World
How 60 Degrees Pharmaceuticals Inc. Equity Warrant stock performs in high volatility markets2025 Earnings Impact & Risk Controlled Daily Trade Plans - newser.com
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant see short term momentumPortfolio Update Report & High Yield Stock Recommendations - newser.com
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock sustain free cash flow growthJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com
Is 60 Degrees Pharmaceuticals Inc. stock oversold or undervaluedPortfolio Risk Summary & Safe Capital Allocation Plans - newser.com
Will 60 Degrees Pharmaceuticals Inc. stock attract more institutional investors2025 Volatility Report & Expert Curated Trade Setups - newser.com
What technical charts say about 60 Degrees Pharmaceuticals Inc. Equity Warrant stockWeekly Trade Recap & Weekly Breakout Watchlists - newser.com
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock maintain operating margins2025 Trading Volume Trends & Safe Entry Zone Tips - newser.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail
How to integrate 60 Degrees Pharmaceuticals Inc. Equity Warrant into portfolio analysis toolsSell Signal & AI Enhanced Trade Execution Alerts - newser.com
60 Degrees Pharmaceuticals Inc (SXTP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.18%
0.62%
자본화:
|
볼륨(24시간):